Free tool
FAERS Monitor: Effient
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 022307 or its brand name (Effient, Prasugrel Hydrochloride). Reports on generic versions are filed under their own applications.
Reports
10,151
Serious
7,609
75% of reports
Hospitalization
3,996
Death reported
862
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- myocardial infarction510
- gastrointestinal haemorrhage472
- chest pain460
- haemorrhage454
- dyspnoea436
- contusion425
- fatigue333
- off label use324
- nausea308
- dizziness302
- thrombosis in device284
- epistaxis254
- headache251
- asthenia228
- diarrhoea224
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2008 | 1 |
| 2009 | 56 |
| 2010 | 598 |
| 2011 | 786 |
| 2012 | 827 |
| 2013 | 502 |
| 2014 | 545 |
| 2015 | 2,703 |
| 2016 | 817 |
| 2017 | 667 |
| 2018 | 503 |
| 2019 | 414 |
| 2020 | 259 |
| 2021 | 216 |
| 2022 | 379 |
| 2023 | 321 |
| 2024 | 167 |
| 2025 | 209 |
| 2026 | 181 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,044,008 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| thrombosis in deviceSignal | 284 | 196.4 | 174.2 | 50,274 |
| gastrointestinal haemorrhageSignal | 472 | 11.8 | 10.8 | 4,629 |
| contusionSignal | 425 | 9.2 | 8.4 | 3,091 |
| haemorrhageSignal | 454 | 9.0 | 8.3 | 3,238 |
| epistaxisSignal | 254 | 7.1 | 6.2 | 1,315 |
| myocardial infarctionSignal | 510 | 6.1 | 5.6 | 2,167 |
| chest painSignal | 460 | 5.2 | 4.7 | 1,547 |
| dyspnoea | 436 | 1.6 | 1.5 | 99 |
| asthenia | 228 | 1.3 | 1.1 | 12 |
| dizziness | 302 | 1.3 | 1.1 | 16 |
| fatigue | 333 | 0.9 | 0.8 | 5 |
| headache | 251 | 0.8 | 0.7 | 9 |
| nausea | 308 | 0.8 | 0.7 | 15 |
| off label use | 324 | 0.8 | 0.7 | 24 |
| diarrhoea | 224 | 0.7 | 0.6 | 25 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.